Chemotherapy Devices Market
Chemotherapy Devices Market - Global Industry Assessment & Forecast
#
Pages:
166
2022
Feb - 2022
VMR-1310
Segments Covered
By
Product Catheter, Cannula, Pump, Others
-
By
Application Hospital, Clinics, Home Care
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 11.80 Billion |
 Revenue 2030:
|
USD 20.71 Billion |
 Revenue CAGR
(2023 - 2030): |
7.30% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Chemotherapy Devices Market by Product by Application by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
Vantage Market
Research | 24-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for Chemotherapy Devices in terms of revenue?
-
The global Chemotherapy Devices valued at USD 11.80 Billion in 2022 and is expected to reach USD 20.71 Billion in 2030 growing at a CAGR of 7.30%.
Which are the prominent players in the market?
-
The prominent players in the market are Advanced Chemotherapy Technologies (US), Baxter International (US), Becton Dickinson (US), B. Braun (Germany), Fresenius Kabi (Germany), Halyard Health (US), ICU Medical (US), Moog Inc (US), Micrel Medical (Sweden), Smiths Group (UK), Terumo Corporation (Japan), and Zyno Medical (US)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.30% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Chemotherapy Devices include
- Rising Cancer Incidences
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Chemotherapy Devices in 2022.
